The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2016

Filed:

Apr. 13, 2015
Applicant:

California Institute of Technology, Pasadena, CA (US);

Inventors:

Niema Pahlevan, Pasadena, CA (US);

Peyman Tavallali, Pasadena, CA (US);

Thomas Yizhao Hou, Arcadia, CA (US);

Morteza Gharib, Altadena, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/05 (2006.01); A61B 5/024 (2006.01); A61B 5/00 (2006.01); A61B 8/02 (2006.01); A61B 8/08 (2006.01); A61B 8/00 (2006.01); A61B 5/02 (2006.01); A61B 8/06 (2006.01);
U.S. Cl.
CPC ...
A61B 5/02416 (2013.01); A61B 5/0004 (2013.01); A61B 5/0077 (2013.01); A61B 5/02028 (2013.01); A61B 5/02405 (2013.01); A61B 5/0507 (2013.01); A61B 5/7235 (2013.01); A61B 5/7278 (2013.01); A61B 5/7282 (2013.01); A61B 5/746 (2013.01); A61B 8/02 (2013.01); A61B 8/06 (2013.01); A61B 8/5223 (2013.01); A61B 8/565 (2013.01);
Abstract

Hardware and software methodology are described for cardiac health measurement. Hemodynamic waveforms variously acquired for a subject are analyzed to calculate or approximate intrinsic frequencies in two domains in two domains across the Dicrotic Notch. The intrinsic frequencies provide metrics/measures that correlate to the cardiac health of the subject. The systems may be used for monitoring a condition and/or is diagnosis. Exemplary uses include identifying (diagnosing) the presence of arrhythmia, heat failure, atrial fibrillation, aneurysms, vessel stenosis or aortic valve dysfunction and the necessity for valve replacement and/or monitoring congestive heart failure progression, together with identifying the acute need for hospitalization in connection with daily testing for any such condition.


Find Patent Forward Citations

Loading…